FDA Oncology

Exploring religious literacy and spirituality in cancer care – FDA Oncology

FDA Oncology shared on X:

“July 10 panelist, Paul Galchutt, serves as assistant director of engagement, Transforming Chaplaincy, an organization committed to advancing spiritual care through research.

He is a palliative care PhD student at the University of Maryland, Baltimore and a Cambia Sojourns Scholar.”

Read further.
Source: FDA Oncology/X

Cambia Sojourns Scholar cancer FDA Oncology OncoDaily Oncology Paul Galchutt University of Maryland